Antifibrotic effects of N-acetyl-seryl-aspartyl-lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats

Hypertension

Volumn 37, Issue 2 II, 2001, Pages 794-800

  Peng, Hongmei ^a   Carretero, Oscar A ^a   Raij, Leopoldo ^b   Yang, Fang ^a   Kapke, Alissa ^a   Rhaleb, Nour Eddine ^a  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Aldosterone; Collagen; Heart; Hypertension; Kidney; Mineralocorticoid

Indexed keywords

ALDOSTERONE; CYCLINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG VEHICLE; RENIN; SERASPENIDE;

ALDOSTERONE BLOOD LEVEL; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE REGULATION; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG MECHANISM; DRUG PROTEIN BINDING; FIBROBLAST; HEART MUSCLE FIBROSIS; HYPERTENSION; MALE; MITOSIS INHIBITION; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION;

EID: 0035095260     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.37.2.794     Document Type: Conference Paper

References (34)

1. Inhibitor of hematopoietic pluripotent stem cell proliferation: Purification and determination of its structure
2. Direct and reversible inhibitory effect of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (Seraspenidel on the growth of human CD34+ subpopulations in response to growth factors
3. Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay
4. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline
5. High plasma level of N-acetyl-seryl-aspartyl-lysyl-proline: A new marker of chronic angiotensin-converting enzyme inhibition
6. In vivo assessment of captopril selectivity of angiotensin I-convening enzyme inhibition: Differential inhibition of acetyl-Ser-Asp-Lys-Pro and angiotensin 1 hydrolysis
7. Ac-SDKP, a new inhibitor of cardiac fibroblast proliferation
8. AcSDKP is a novel anti-proliferative peptide for renal fibroblasts
9. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: Role of kinins and angiotensin II type 2 receptors
10. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium front the spontaneously hypertensive rat
11. Angiotensin-convening enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone
12. Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats
13. Enalapril reduces collagen type IV, synthesis and expansion of the interstitium in the obstructed kidney of the rat
14. Mineralocorticoids, hypertension, and cardiac fibrosis
15. Local angiotensin II and transforming growth factor-β1 in renal fibrosis of rats
16. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone
17. Collagen remodeling after myocardial infarction in the rat heart
18. A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion
19. Griffonia simplicifolia I: Fluorescent tracer for microcirculatory vessels in nonperfused thin muscles and sectioned muscle
20. Griffonia simplicifolia lectins bind specifically to endothelial cells and some epithelial cells in mouse tissues
21. Progression of heart failure: A role for interstitial fibrosis
22. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats
23. Nitric oxide synthase activity and renal injury in genetic hypertension
24. Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system
25. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme
26. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension
27. Remodeling of the rat right and left ventricles in experimental hypertension
28. Plasma kinin concentration in deoxycorticosterone-salt hypertension
29. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction
30. The pathophysiology of obstructive nephropathy: The role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney
31. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta
32. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines
33. In vivo effect of the tetrapeptide. N-acetyl-Ser-Asp-Lys-Pro, on the GI-S transition of rat hepatocytes
34. Effects of angiotensin-converting enzyme inhibition on plasma, urine, and tissue concentrations of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro in rats